Abstract
Orthotopic liver transplantation remains the only proven cure for end-stage liver failure. Despite significant advances in the field, the clinical demand for donor organs far outweighs the supply. Hepatocyte transplantation has been proposed as an alternative approach to whole liver transplant in select diseases. Several international centers have reported experimental trials of human hepatocyte transplantation in acute liver failure and liver-based metabolic disorders. This chapter provides an introduction to hepatocyte transplantation from both a technical and clinical perspective. We will also focus on the special needs of pediatric patients, since historically the majority of clinical hepatocyte transplants have involved infants and children.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR (1963) Homotransplantation of the liver in humans. Surg Gynecol Obstet 117:659–676
McDiarmid SV, Anand R, Lindblad AS, Principal Investigators and Institutions of the Studies of Pediatric Liver Transplantation Research Group (2002) Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74(2):173–181
Fisher RA, Strom SC (2006) Human hepatocyte transplantation: worldwide results. Transplantation 82(4):441–449. doi:10.1097/01.tp.0000231689.44266.ac
Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, Dorko K, Sauter BV, Strom SC (1998) Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338(20):1422–1426. doi:10.1056/NEJM199805143382004
Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, Strom SC, Fox IJ (2003) Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111(6 Pt 1):1262–1267
Dhawan A (2015) Clinical human hepatocyte transplantation—current status and challenges. Liver Transpl. doi:10.1002/lt.24226
Puppi J, Strom SC, Hughes RD, Bansal S, Castell JV, Dagher I, Ellis EC, Nowak G, Ericzon BG, Fox IJ, Gomez-Lechon MJ, Guha C, Gupta S, Mitry RR, Ohashi K, Ott M, Reid LM, Roy-Chowdhury J, Sokal E, Weber A, Dhawan A (2012) Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant 21(1):1–10. doi:10.3727/096368911x566208
Gramignoli R, Vosough M, Kannisto K, Srinivasan RC, Strom SC (2015) Clinical hepatocyte transplantation: practical limits and possible solutions. Eur Surg Res 54(3–4):162–177. doi:10.1159/000369552
Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, Posner MP (1997) Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63(4):559–569
Hughes RD, Mitry RR, Dhawan A, Lehec SC, Girlanda R, Rela M, Heaton ND, Muiesan P (2006) Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl 12(5):713–717. doi:10.1002/lt.20732
Gastaca M (2009) Extended criteria donors in liver transplantation: adapting donor quality and recipient. Transplant Proc 41(3):975–979. doi:10.1016/j.transproceed.2009.02.016
Gramignoli R, Tahan V, Dorko K, Skvorak KJ, Hansel MC, Zhao W, Venkataramanan R, Ellis EC, Jorns C, Ericzon BG, Rosenborg S, Kuiper R, Soltys KA, Mazariegos GV, Fox IJ, Wilson EM, Grompe M, Strom SC (2013) New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants. Stem Cell Res 11(1):563–573. doi:10.1016/j.scr.2013.03.002
Kleine M, Riemer M, Krech T, DeTemple D, Jager MD, Lehner F, Manns MP, Klempnauer J, Borlak J, Bektas H, Vondran FW (2014) Explanted diseased livers—a possible source of metabolic competent primary human hepatocytes. PLoS One 9(7):e101386. doi:10.1371/journal.pone.0101386
Bhogal RH, Hodson J, Bartlett DC, Weston CJ, Curbishley SM, Haughton E, Williams KT, Reynolds GM, Newsome PN, Adams DH, Afford SC (2011) Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 6(3):e18222. doi:10.1371/journal.pone.0018222
Tolosa L, Pareja-Ibars E, Donato MT, Cortes M, Lopez S, Jimenez N, Mir J, Castell JV, Gomez-Lechon MJ (2014) Neonatal livers: a source for the isolation of good-performing hepatocytes for cell transplantation. Cell Transplant 23(10):1229–1242. doi:10.3727/096368913X669743
Habibullah CM, Syed IH, Qamar A, Taher-Uz Z (1994) Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 58(8):951–952
Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA, Srinivas G, Raj TA, Tiwari SK, Kumaresan K, Venkateswarlu J, Pande G, Habibullah CM (2010) Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant 19(4):409–418. doi:10.3727/096368910X498241
Pietrosi G, Vizzini G, Gerlach J, Chinnici C, Luca A, Amico G, D’Amato M, Conaldi PG, Li Petri S, Spada M, Tuzzolino F, Alio L, Schmelzer E, Gridelli B (2015) Phases I–II matched case-control study of human fetal liver cell transplantation for treatment of chronic liver disease. Cell Transplant 24(8):1627–1638. doi:10.3727/096368914x682422
Enosawa S, Horikawa R, Yamamoto A, Sakamoto S, Shigeta T, Nosaka S, Fujimoto J, Nakazawa A, Tanoue A, Nakamura K, Umezawa A, Matsubara Y, Matsui A, Kasahara M (2014) Hepatocyte transplantation using a living donor reduced graft in a baby with ornithine transcarbamylase deficiency: a novel source of hepatocytes. Liver Transpl 20(3):391–393. doi:10.1002/lt.23800
Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, Ellis E, van Wenum M, Fuchs SA, de Ligt J, van de Wetering M, Sasaki N, Boers SJ, Kemperman H, de Jonge J, Ijzermans JN, Nieuwenhuis EE, Hoekstra R, Strom S, Vries RR, van der Laan LJ, Cuppen E, Clevers H (2015) Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160(1–2):299–312. doi:10.1016/j.cell.2014.11.050
Miki T, Marongiu F, Ellis EC, Dorko K, Mitamura K, Ranade A, Gramignoli R, Davila J, Strom SC (2009) Production of hepatocyte-like cells from human amnion. Methods Mol Biol (Clifton, NJ) 481:155–168. doi:10.1007/978-1-59745-201-4_13
Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, Zhang A, Shi J, Chen L, Lv S, He W, Geng H, Jin L, Liu Z, Wang FS (2012) Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med 1(10):725–731. doi:10.5966/sctm.2012-0034
Grossman M, Raper SE, Wilson JM (1992) Transplantation of genetically modified autologous hepatocytes into nonhuman primates: feasibility and short-term toxicity. Hum Gene Ther 3(5):501–510. doi:10.1089/hum.1992.3.5-501
Guha C, Yamanouchi K, Jiang J, Wang X, Roy Chowdhury N, Santana A, Shapiro LJ, Salido E, Roy-Chowdhury J (2005) Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias. Am J Nephrol 25(2):161–170. doi:10.1159/000085408
Joseph B, Kumaran V, Berishvili E, Bhargava KK, Palestro CJ, Gupta S (2006) Monocrotaline promotes transplanted cell engraftment and advances liver repopulation in rats via liver conditioning. Hepatology 44(6):1411–1420. doi:10.1002/hep.21416
Laconi E, Oren R, Mukhopadhyay DK, Hurston E, Laconi S, Pani P, Dabeva MD, Shafritz DA (1998) Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 153(1):319–329. doi:10.1016/S0002-9440(10)65574-5
Mignon A, Guidotti JE, Mitchell C, Fabre M, Wernet A, De La Coste A, Soubrane O, Gilgenkrantz H, Kahn A (1998) Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes. Nat Med 4(10):1185–1188. doi:10.1038/2681
Dagher I, Boudechiche L, Branger J, Coulomb-Lhermine A, Parouchev A, Sentilhes L, Lin T, Groyer-Picard MT, Vons C, Hadchouel M, Pariente D, Andreoletti M, Franco D, Weber A (2006) Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization. Transplantation 82(8):1067–1073. doi:10.1097/01.tp.0000236103.99456.8f
Yamanouchi K, Zhou H, Roy-Chowdhury N, Macaluso F, Liu L, Yamamoto T, Yannam GR, Enke C, Solberg TD, Adelson AB, Platt JL, Fox IJ, Roy-Chowdhury J, Guha C (2009) Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology 49(1):258–267. doi:10.1002/hep.22573
Sempoux C, Horsmans Y, Geubel A, Fraikin J, Van Beers BE, Gigot JF, Lerut J, Rahier J (1997) Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: activation of hepatic stellate cells as an early event. Hepatology 26(1):128–134. doi:10.1002/hep.510260117
Stephenne X, Najimi M, Janssen M, Reding R, de Ville de Goyet J, Sokal EM (2005) Liver allograft radiotherapy to treat rejection in children: efficacy in orthotopic liver transplantation and long-term safety. Liver Int 25(6):1108–1113. doi:10.1111/j.1478-3231.2005.01152.x
Mitry RR, Hughes RD, Aw MM, Terry C, Mieli-Vergani G, Girlanda R, Muiesan P, Rela M, Heaton ND, Dhawan A (2003) Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant 12(1):69–74
Jorns C, Nowak G, Nemeth A, Zemack H, Mork LM, Johansson H, Gramignoli R, Watanabe M, Karadagi A, Alheim M, Hauzenberger D, van Dijk R, Bosma PJ, Ebbesen F, Szakos A, Fischler B, Strom S, Ellis E, Ericzon BG (2015) De novo donor-specific HLA antibody formation in two patients with Crigler-Najjar syndrome type I following human hepatocyte transplantation with partial hepatectomy preconditioning. Am J Transplant. doi:10.1111/ajt.13487
Mei J, Sgroi A, Mai G, Baertschiger R, Gonelle-Gispert C, Serre-Beinier V, Morel P, Buhler LH (2009) Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice. Cell Transplant 18(1):101–110
Bohnen NI, Charron M, Reyes J, Rubinstein W, Strom SC, Swanson D, Towbin R (2000) Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin Nucl Med 25(6):447–450
Kammer NN, Billecke N, Morgul MH, Adonopoulou MK, Mogl M, Huang MD, Florek S, Schmitt KR, Raschzok N, Sauer IM (2011) Labeling of primary human hepatocytes with micron-sized iron oxide particles in suspension culture suitable for large-scale preparation. Artif Organs 35(4):E91–E100. doi:10.1111/j.1525-1594.2010.01177.x
Puppi J, Mitry RR, Modo M, Dhawan A, Raja K, Hughes RD (2011) Use of a clinically approved iron oxide MRI contrast agent to label human hepatocytes. Cell Transplant 20(6):963–975. doi:10.3727/096368910x543367
Puppi J, Modo M, Dhawan A, Lehec SC, Mitry RR, Hughes RD (2014) Ex vivo magnetic resonance imaging of transplanted hepatocytes in a rat model of acute liver failure. Cell Transplant 23(3):329–343. doi:10.3727/096368913x663596
Puppi J, Dhawan A (2009) Human hepatocyte transplantation overview. Methods Mol Biol (Clifton, NJ) 481:1–16. doi:10.1007/978-1-59745-201-4_1
Soriano HE, Wood RP, Kang DC, Ozaki CF, Finegold MJ, Bischoff FC, Reid BS et al (1997) Hepatocyte transplantation (HCT) in children with fulminant liver failure (FLF). Hepatology 26(239A):443
Strom SC, Chowdhury JR, Fox IJ (1999) Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 19(1):39–48. doi:10.1055/s-2007-1007096
Sterling RK, Fisher RA (2001) Liver transplantation. Living donor, hepatocyte, and xenotransplantation. Clin Liver Dis 5(2):431–460, vii
Meyburg J, Hoerster F, Schmidt J, Poeschl J, Hoffmann GF, Schenk JP (2010) Monitoring of intraportal liver cell application in children. Cell Transplant 19(5):629–638. doi:10.3727/096368909X485058
Darwish AA, Sokal E, Stephenne X, Najimi M, de Goyet JV, Reding R (2004) Permanent access to the portal system for cellular transplantation using an implantable port device. Liver Transpl 10(9):1213–1215. doi:10.1002/lt.20228
Ambrosino G, Varotto S, Strom SC, Guariso G, Franchin E, Miotto D, Caenazzo L, Basso S, Carraro P, Valente ML, D’Amico D, Zancan L, D’Antiga L (2005) Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant 14(2–3):151–157
Dhawan A, Mitry RR, Hughes RD (2006) Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 29(2–3):431–435. doi:10.1007/s10545-006-0245-8
Allen KJ, Mifsud NA, Williamson R, Bertolino P, Hardikar W (2008) Cell-mediated rejection results in allograft loss after liver cell transplantation. Liver Transpl 14(5):688–694. doi:10.1002/lt.21443
Lysy PA, Najimi M, Stephenne X, Bourgois A, Smets F, Sokal EM (2008) Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives. World J Gastroenterol 14(22):3464–3470
Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakash HR, Venkateswarlu J, Rao P, Pande G, Narusu ML, Khaja MN, Pramila R, Habeeb A, Habibullah CM (2008) Treatment of Crigler-Najjar Syndrome type 1 by hepatic progenitor cell transplantation: a simple procedure for management of hyperbilirubinemia. Transplant Proc 40(4):1148–1150. doi:10.1016/j.transproceed.2008.03.022
Ribes-Koninckx C, Ibars EP, Calzado Agrasot MA, Bonora-Centelles A, Miquel BP, Vila Carbo JJ, Aliaga ED, Pallardo JM, Gomez-Lechon MJ, Castell JV (2012) Clinical outcome of hepatocyte transplantation in four pediatric patients with inherited metabolic diseases. Cell Transplant 21(10):2267–2282. doi:10.3727/096368912X637505
Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ III, Stein EA, Lupien PJ, Brewer HB Jr, Raper SE et al (1995) A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1(11):1148–1154
Dhawan A, Mitry RR, Hughes RD, Lehec S, Terry C, Bansal S, Arya R, Wade JJ, Verma A, Heaton ND, Rela M, Mieli-Vergani G (2004) Hepatocyte transplantation for inherited factor VII deficiency. Transplantation 78(12):1812–1814
Stephenne X, Debray FG, Smets F, Jazouli N, Sana G, Tondreau T, Menten R, Goffette P, Boemer F, Schoos R, Gersting SW, Najimi M, Muntau AC, Goyens P, Sokal EM (2012) Hepatocyte transplantation using the domino concept in a child with tetrabiopterin nonresponsive phenylketonuria. Cell Transplant 21(12):2765–2770. doi:10.3727/096368912X653255
Lee KW, Lee JH, Shin SW, Kim SJ, Joh JW, Lee DH, Kim JW, Park HY, Lee SY, Lee HH, Park JW, Kim SY, Yoon HH, Jung DH, Choe YH, Lee SK (2007) Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant 16(6):629–637
Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R, Bernard Otte J, Evrard V, Latinne D, Vincent MF, Moser A, Soriano HE (2003) Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up. Transplantation 76(4):735–738. doi:10.1097/01.TP.0000077420.81365.53
Beck BB, Habbig S, Dittrich K, Stippel D, Kaul I, Koerber F, Goebel H, Salido EC, Kemper M, Meyburg J, Hoppe B (2012) Liver cell transplantation in severe infantile oxalosis—a potential bridging procedure to orthotopic liver transplantation? Nephrol Dial Transplant 27(7):2984–2989. doi:10.1093/ndt/gfr776
Strom SC, Fisher RA, Rubinstein WS, Barranger JA, Towbin RB, Charron M, Mieles L, Pisarov LA, Dorko K, Thompson MT, Reyes J (1997) Transplantation of human hepatocytes. Transplant Proc 29(4):2103–2106
Stephenne X, Najimi M, Smets F, Reding R, de Ville de Goyet J, Sokal EM (2005) Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 5(8):2058–2061. doi:10.1111/j.1600-6143.2005.00935.x
Puppi J, Tan N, Mitry RR, Hughes RD, Lehec S, Mieli-Vergani G, Karani J, Champion MP, Heaton N, Mohamed R, Dhawan A (2008) Hepatocyte transplantation followed by auxiliary liver transplantation—a novel treatment for ornithine transcarbamylase deficiency. Am J Transplant 8(2):452–457. doi:10.1111/j.1600-6143.2007.02058.x
Meyburg J, Das AM, Hoerster F, Lindner M, Kriegbaum H, Engelmann G, Schmidt J, Ott M, Pettenazzo A, Luecke T, Bertram H, Hoffmann GF, Burlina A (2009) One liver for four children: first clinical series of liver cell transplantation for severe neonatal urea cycle defvects. Transplantation 87(5):636–641. doi:10.1097/TP.0b013e318199936a
Mitry RR, Dhawan A, Hughes RD, Bansal S, Lehec S, Terry C, Heaton ND, Karani JB, Mieli-Vergani G, Rela M (2004) One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation 77(10):1614–1616
Stephenne X, Najimi M, Sibille C, Nassogne MC, Smets F, Sokal EM (2006) Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology 130(4):1317–1323. doi:10.1053/j.gastro.2006.01.008
Meyburg J, Alexandrova K, Barthold M, Kafert-Kasting S, Schneider AS, Attaran M, Hoerster F, Schmidt J, Hoffmann GF, Ott M (2009) Liver cell transplantation: basic investigations for safe application in infants and small children. Cell Transplant 18(7):777–786. doi:10.3727/096368909X470775
Acknowledgements
Dr. Khan acknowledges grant support from NIH/NICHD PHS K12HD052892, the Alpha-1 Foundation, and the Hillman Foundation. Dr. Strom acknowledges grant support from Torsten och Ragnar Söderberg Stiftelse (Foundation) and the Center for Innovative Medicine.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Khan, Z., Strom, S.C. (2017). Hepatocyte Transplantation in Special Populations: Clinical Use in Children. In: Stock, P., Christ, B. (eds) Hepatocyte Transplantation. Methods in Molecular Biology, vol 1506. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6506-9_1
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6506-9_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6504-5
Online ISBN: 978-1-4939-6506-9
eBook Packages: Springer Protocols